BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11544425)

  • 1. Primum non nocere: avoiding harm to vulnerable wait list candidates in an indirect kidney exchange.
    Zenios SA; Woodle ES; Ross LF
    Transplantation; 2001 Aug; 72(4):648-54. PubMed ID: 11544425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restricting living-donor-cadaver-donor exchanges to ensure that standard blood type O wait-list candidates benefit.
    Ross LF; Zenios S
    Transplantation; 2004 Sep; 78(5):641-6. PubMed ID: 15371662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UNOS OPTN waiting list and donor registry.
    Harper AM; Rosendale JD
    Clin Transpl; 1997; ():61-80. PubMed ID: 9919391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in increasing living kidney donations by expanding kidney paired exchange programs.
    Ross LF; Woodle ES
    Transplantation; 2000 Apr; 69(8):1539-43. PubMed ID: 10836356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dutch national living donor kidney exchange program.
    de Klerk M; Keizer KM; Claas FH; Witvliet M; Haase-Kromwijk BJ; Weimar W
    Am J Transplant; 2005 Sep; 5(9):2302-5. PubMed ID: 16095513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?
    Nelson PW; Shield CF; Muruve NA; Murillo D; Warady BA; Aeder MI; Bryan CF
    Am J Transplant; 2002 Jan; 2(1):94-9. PubMed ID: 12095063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trading with the waiting-list: the justice of living donor list exchange.
    den Hartogh G
    Bioethics; 2010 May; 24(4):190-8. PubMed ID: 20394110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UNOS OPTN waiting list and donor registry.
    Harper AM; Rosendale JD; McBride MA; Cherikh WS; Ellison MD
    Clin Transpl; 1998; ():73-90. PubMed ID: 10503086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor kidney exchanges.
    Delmonico FL; Morrissey PE; Lipkowitz GS; Stoff JS; Himmelfarb J; Harmon W; Pavlakis M; Mah H; Goguen J; Luskin R; Milford E; Basadonna G; Chobanian M; Bouthot B; Lorber M; Rohrer RJ
    Am J Transplant; 2004 Oct; 4(10):1628-34. PubMed ID: 15367217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor kidney exchange for both ABO-incompatible and crossmatch positive donor-recipient combinations.
    de Klerk M; Haase-Kromwijk BJ; Claas FH; Witvliet M; Weimar W
    Transplant Proc; 2006 Nov; 38(9):2793-5. PubMed ID: 17112831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 'blood group O problem' in kidney transplantation--time to change?
    Glander P; Budde K; Schmidt D; Fuller TF; Giessing M; Neumayer HH; Liefeldt L
    Nephrol Dial Transplant; 2010 Jun; 25(6):1998-2004. PubMed ID: 20100733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of minority patients with end-stage renal disease regarding ABO-incompatible list-paired exchanges.
    Ackerman PD; Thistlethwaite JR; Ross LF
    Am J Transplant; 2006 Jan; 6(1):83-8. PubMed ID: 16433760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplant chains amplify benefit of nondirected donors.
    Melcher ML; Veale JL; Javaid B; Leeser DB; Davis CL; Hil G; Milner JE
    JAMA Surg; 2013 Feb; 148(2):165-9. PubMed ID: 23426593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of nonidentical ABO deceased donor kidney transplant on kidney utilization.
    Kayler LK; Segev DL
    Am J Kidney Dis; 2010 Jul; 56(1):95-101. PubMed ID: 20347513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UNOS OPTN Waiting List and Donor Registry: 1988-1996.
    Harper AM; Rosendale JD
    Clin Transpl; 1996; ():69-90. PubMed ID: 9286559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys.
    Bryan CF; Shield CF; Nelson PW; Pierce GE; Ross G; Luger AM; Warady BA; Helling TS; Aeder MI; Martinez J; Hughes TM; Beck ML; Harrell KM
    Transplantation; 1998 Dec; 66(12):1714-7. PubMed ID: 9884265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.
    Bryan CF; Nelson PW; Shield CF; Ross G; Warady B; Murillo D; Winklhofer FT
    Clin Transpl; 2004; ():127-33. PubMed ID: 16704145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the living organ donor pool: positive crossmatch and ABO incompatible renal transplantation.
    Holechek MJ; Hiller JM; Paredes M; Rickard JC; Montgomery RA
    Nephrol Nurs J; 2003 Apr; 30(2):195-204. PubMed ID: 12736998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of different kidney exchange mechanisms to improve living donor transplantation in Chile.
    Domínguez J; Harrison R; Contreras D
    Transplant Proc; 2011; 43(6):2283-7. PubMed ID: 21839256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.
    de Klerk M; Kal-van Gestel JA; Haase-Kromwijk BJ; Claas FH; Weimar W;
    Clin Transpl; 2011; ():287-90. PubMed ID: 22755421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.